Abiomed (ABMD) Posts Q3 Adj-EPS of $0.70
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ABIOMED (ABMD) PT Raised to $274 at Stephens
February 2, 2018 7:24 AM ESTStephens raised its price target on ABIOMED (NASDAQ: ABMD) to $274.00 (from $190.00) while maintaining a Overweight rating.
... MoreABIOMED (ABMD) PT Raised to $300 at Jefferies; 'Nothing But Blue Skies'
February 1, 2018 12:51 PM ESTJefferies raised its price target on ABIOMED (NASDAQ: ABMD) to $300.00 (from $250.00) while maintaining a Buy rating following strong results.
... More